Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 7
2005 6
2006 3
2007 3
2008 3
2009 3
2010 5
2011 7
2012 8
2013 8
2014 11
2015 9
2016 10
2017 5
2018 3
2019 5
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
Zimmermann G, Papke B, Ismail S, Vartak N, Chandra A, Hoffmann M, Hahn SA, Triola G, Wittinghofer A, Bastiaens PI, Waldmann H. Zimmermann G, et al. Among authors: hahn sa. Nature. 2013 May 30;497(7451):638-42. doi: 10.1038/nature12205. Epub 2013 May 22. Nature. 2013. PMID: 23698361
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, Erkan M, Kleeff J, Sipos B, Sayles LC, Heikenwalder M, Heßmann E, Ellenrieder V, Esposito I, Jacks T, Bradner JE, Khatri P, Sweet-Cordero EA, Attardi LD, Schmid RM, Schneider G, Sage J, Siveke JT. Mazur PK, et al. Among authors: hahn sa. Nat Med. 2015 Oct;21(10):1163-71. doi: 10.1038/nm.3952. Epub 2015 Sep 21. Nat Med. 2015. PMID: 26390243 Free PMC article.
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer.
Weisner J, Landel I, Reintjes C, Uhlenbrock N, Trajkovic-Arsic M, Dienstbier N, Hardick J, Ladigan S, Lindemann M, Smith S, Quambusch L, Scheinpflug R, Depta L, Gontla R, Unger A, Müller H, Baumann M, Schultz-Fademrecht C, Günther G, Maghnouj A, Müller MP, Pohl M, Teschendorf C, Wolters H, Viebahn R, Tannapfel A, Uhl W, Hengstler JG, Hahn SA, Siveke JT, Rauh D. Weisner J, et al. Among authors: hahn sa. Cancer Res. 2019 May 1;79(9):2367-2378. doi: 10.1158/0008-5472.CAN-18-2861. Epub 2019 Mar 11. Cancer Res. 2019. PMID: 30858154 Free article.
A genetic roadmap of pancreatic cancer: still evolving.
Notta F, Hahn SA, Real FX. Notta F, et al. Among authors: hahn sa. Gut. 2017 Dec;66(12):2170-2178. doi: 10.1136/gutjnl-2016-313317. Epub 2017 Oct 9. Gut. 2017. PMID: 28993418 Review.
MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
Baraniskin A, Chomiak M, Ahle G, Gress T, Buchholz M, Turewicz M, Eisenacher M, Margold M, Schlegel U, Schmiegel W, Hahn S, Schroers R. Baraniskin A, et al. Among authors: hahn s. J Neurooncol. 2018 May;137(3):463-468. doi: 10.1007/s11060-018-2749-0. Epub 2018 Jan 11. J Neurooncol. 2018. PMID: 29327175
Deregulated miR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis.
Klatt CL, Theis V, Hahn S, Theiss C, Matschke V. Klatt CL, et al. Among authors: hahn s. Cells. 2019 Sep 12;8(9):1077. doi: 10.3390/cells8091077. Cells. 2019. PMID: 31547454 Free PMC article.
Activation leads to a significant shift in the intracellular redox homeostasis of neutrophil-like cells.
Xie K, Varatnitskaya M, Maghnouj A, Bader V, Winklhofer KF, Hahn S, Leichert LI. Xie K, et al. Among authors: hahn s. Redox Biol. 2020 Jan;28:101344. doi: 10.1016/j.redox.2019.101344. Epub 2019 Oct 13. Redox Biol. 2020. PMID: 31639650 Free PMC article.
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
Cioffi M, Trabulo SM, Sanchez-Ripoll Y, Miranda-Lorenzo I, Lonardo E, Dorado J, Reis Vieira C, Ramirez JC, Hidalgo M, Aicher A, Hahn S, Sainz B Jr, Heeschen C. Cioffi M, et al. Among authors: hahn s. Gut. 2015 Dec;64(12):1936-48. doi: 10.1136/gutjnl-2014-308470. Epub 2015 Apr 17. Gut. 2015. PMID: 25887381 Free PMC article.
Long-noncoding RNAs in basal cell carcinoma.
Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S. Sand M, et al. Among authors: hahn sa. Tumour Biol. 2016 Aug;37(8):10595-608. doi: 10.1007/s13277-016-4927-z. Epub 2016 Feb 9. Tumour Biol. 2016. PMID: 26861560
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular level.
Hammoud MK, Yosef HK, Lechtonen T, Aljakouch K, Schuler M, Alsaidi W, Daho I, Maghnouj A, Hahn S, El-Mashtoly SF, Gerwert K. Hammoud MK, et al. Among authors: hahn s. Sci Rep. 2018 Oct 15;8(1):15278. doi: 10.1038/s41598-018-33682-7. Sci Rep. 2018. PMID: 30323297 Free PMC article.
94 results
Jump to page
Feedback